Notice2024-15967
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 19, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 139 (Friday, July 19, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 139 (Friday, July 19, 2024)]
[Notices]
[Pages 58736-58737]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-15967]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-0978]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Emerging Infections Program (EIP)'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on February 29, 2024 to obtain
comments from the public and affected agencies. CDC received one non-
substantive comment. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Emerging Infections Program (EIP) (OMB Control No. 0920-0978, Exp.
2/28/2026)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIP) are population-based centers
of excellence established through a network of state health departments
collaborating with academic institutions; local health departments;
public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases. Activities of the EIPs fall into the
following general categories: (1) active surveillance; (2) applied
public health epidemiologic and laboratory activities; (3)
implementation and evaluation of pilot prevention/intervention
projects; and (4) flexible response to public health emergencies.
Activities of the EIPs are designed to: (1) address issues that the EIP
network is particularly suited to investigate; (2) maintain sufficient
flexibility for emergency response and new problems as they arise; (3)
develop and evaluate public health interventions to inform public
health policy and treatment guidelines; (4) incorporate training as a
key function; and (5) prioritize projects that lead directly to the
prevention of disease. Activities in the EIP Network to which all
applicants must participate are:
[[Page 58737]]
<bullet> Active Bacterial Core surveillance (ABCs): active
population-based laboratory surveillance for invasive bacterial
diseases.
<bullet> Foodborne Diseases Active Surveillance Network (FoodNet):
active population-based laboratory surveillance to monitor the
incidence of select enteric diseases.
<bullet> Influenza: active population-based surveillance for
laboratory confirmed influenza-related hospitalizations.
<bullet> Healthcare-Associated Infections-Community Interface
(HAIC) surveillance: active population-based surveillance for
healthcare-associated pathogens and infections.
A Revision is being submitted to make existing collection
instruments clearer and to add several new forms specifically surveying
laboratory practices. These forms will allow the EIP to better detect,
identify, track changes in laboratory testing methodology, gather
information about laboratory utilization in the EIP catchment area to
ensure that all cases are being captured, and survey EIP staff to
evaluate program quality.
CDC requests OMB approval for an estimated 41,483 annual burden
hours. There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form No. Form name Number of responses per per response
respondents respondent (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Health Department........................... ABC.100.1................. ABCs Case Report Form... 10 809 20/60
ABC.100.2................. ABCs Invasive 10 127 10/60
Pneumococcal Disease in
Children and Adults
Case Report Form.
ABC.100.3................. ABCs H. influenzae 10 6 10/60
Neonatal Sepsis
Expanded Surveillance
Form.
ABC.100.4................. ABCs Severe GAS 10 136 20/60
Infection Supplemental
Form.
ABC.100.5................. ABCs Neonatal Infection 10 37 20/60
Expanded Tracking Form.
FN.200.1.................. FoodNet Campylobacter... 10 970 21/60
FN.200.2.................. FoodNet Cyclospora...... 10 42 10/60
FN.200.3.................. FoodNet Listeria 10 16 20/60
monocytogenes.
FN.200.4.................. FoodNet Salmonella...... 10 855 21/60
FN.200.5.................. FoodNet Shiga toxin 10 290 20/60
producing E. coli.
FN.200.6.................. FoodNet Shigella........ 10 234 10/60
FN.200.7.................. FoodNet Vibrio.......... 10 46 10/60
FN.200.8.................. FoodNet Yersinia........ 10 55 10/60
FN.200.9.................. FoodNet Hemolytic Uremic 10 10 1
Syndrome.
FN.200.10................. FoodNet Clinical 10 70 10/60
Laboratory Practices
and Testing Volume.
FSN.300.1................. FluSurv-Net Influenza 15 576 25/60
Hospitalization
Surveillance Network
Case Report Form.
FSN.300.2................. FluSurv-Net Influenza 13 16 10/60
Hospitalization
Surveillance Project
Vaccination Phone
Script and Consent Form
(English/Spanish).
FSN.300.3................. FluSurv-Net Influenza 13 126 5/60
Hospitalization
Surveillance Project
Provider Vaccination
History Fax Form
(Children/Adults)and
notification letter.
FSN.300.4................. FluSurv-NET Laboratory 15 16 10/60
Survey.
HAIC.400.1................ HAIC--Multi-site Gram- 11 1,581 29/60
Negative Surveillance
Initiative (MuGSI) Case
Report Form (CRF).
HAIC.400.2................ HAIC MuGSI CA CP-CRE 10 10 30/60
Health interview.
HAIC.400.3................ HAIC MuGSI Supplemental 11 1 20/60
Surveillance Officer
Survey.
HAIC.400.4................ HAIC--Invasive 10 788 29/60
Staphylococcus aureus
Infection Case Report
Form.
HAIC.400.5................ HAIC--Invasive 10 11 9/60
Staphylococcus aureus
Laboratory Survey.
HAIC.400.6................ HAIC--Invasive 10 1 11/60
Staphylococcus aureus
Supplemental
Surveillance Officers
Survey.
HAIC.400.7................ HAIC--CDI Case Report 10 1,650 38/60
and Treatment Form.
HAIC.400.8................ HAIC--Annual Survey of 10 16 17/60
Laboratory Testing
Practices for C.
difficile Infections.
HAIC.400.9................ HAIC--CDI Annual 10 1 15/60
Surveillance Officers
Survey.
HAIC.400.10............... HAIC--Emerging 10 45 5/60
Infections Program C.
difficile Surveillance
Nursing Home Telephone
Survey (LTCF).
HAIC.400.11............... HAIC Candidemia Case 10 170 40/60
Report Form.
HAIC.400.12............... HAIC--Laboratory Testing 10 20 14/60
Practices for
Candidemia
Questionnaire.
HAIC.400.13............... HAIC Death Ascertainment 10 8 24
Project.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-15967 Filed 7-18-24; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on July 19, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.